Research to Prevention (R2P)


Research to Prevention (R2P) is a five-year HIV prevention project funded by USAID. R2P is led by the Johns Hopkins Center for Global Health and managed by CCP. R2Ppartners with faculty throughout the Johns Hopkins Schools of Public Health, Medicine and Nursing, as well as Tulane University, the Medical University of South Carolina, and the University of North Carolina. R2P seeks to answer the question: What are the most effective interventions for preventing the spread of HIV? R2P aims to promote greater use of evidence in the design and implementation of HIV prevention programs in countries most affected by the HIV epidemic. In partnership with organizations in developing countries, R2P will conduct research to identify the most effective interventions for preventing HIV, promote increased use of data to guide programs and policies, and build capacity for applied research among health professionals.


  • Conducted formative research projects on sexual concurrency in Malawi, Tanzania and South Africa, and drug users in Guatemala.

  • Secured Mission-supported funding for additional research projects in Botswana (alcohol and HIV risk), Mozambique (evaluation of a multiple concurrent partners campaign), and Swaziland (most at risk populations, including sex workers and men who have sex with men).

  • Developed fact sheets synthesizing key research findings on six of the most used HIV prevention interventions.

  • Completed three locally led research studies on alcohol and HIV in the DRC, Ethiopia, and Vietnam. Awarded three grants to local researchers from Kenya, Senegal, and South Africa to conduct research and prepare peer-reviewed publications for studies on men who have sex with men (MSM) and HIV. The awardees attended a workshop in Baltimore in September 2010 where they presented their proposals and received feedback and additional training from R2P staff and expert JHU faculty.

  • Completed final qualitative research reports on HIV and multiple concurrent partnerships in Tanzania and Malawi; and HIV and drug users in Guatemala.